Dr. Bruce Johnson has been the leader of the DF/HCC Lung Cancer Program since joining the DFCI in 1998. He became the Chief Clinical Research Officer at DFCI in 2013 and is a member of the DF/HCC Center Scientific Council. He was the Director of the Lowe Center for Thoracic Oncology from 1998 to 2013. Dr. Johnson’s translational research activities are devoted to identifying genomic predictors of the efficacy of…
John Iafrate, MD,
Dr. John Iafrate is the director of the Center for Integrated Diagnostics, a clinical laboratory for molecular diagnostics at the MGH. He oversees the Translational Research Laboratory (TRL), a shared effort of the Pathology Department and Mass General Cancer Center. The TRL provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. Dr. Iafrate received his MD and PhD from the State University of New York at…
Lynette Sholl, MD
Dr. Lynette Sholl is an Assistant Professor of Pathology at HMS/DFCI/BWH. Her research focuses on identifying pathologic, immunohistochemical, and genetic markers that will improve the classification of lung cancer, provide predictive information regarding therapy, and provide more precise prognostic information. With the advent of high-throughput next-generation sequencing technologies, she is engaged in translation of novel observations surrounding tumors.
Henning Willers, MD
Dr. Henning Willers is an Associate Professor of Radiation Oncology at HMS and MGH. He has researched in radiation biology since 1991 and as a laboratory-based PI since 2005. His basic and translational research activities are directed at furthering our understanding of how NSCLCs respond to radiation and radiosensitizing drugs. Specifically, we seek to identify the signaling pathways that contribute to the radioresistance of KRAS-mutant lung adenocarcinoma which is an…
Michael Lanuti, MD
Dr. Michael Lanuti is a board certified Thoracic Surgeon with special interest in lung cancer research, new techniques for lung cancer staging, and minimally invasive lung surgery.
Xihong Lin, PhD
Dr. Xihong Lin is the Henry Pickering Walcott Professor of Biostatistics, Chair, Department of Biostatistics, HSPH. Dr. Lin is a leading expert in statistical genetics and genomics and statistical methods for epidemiological data and massive data. Dr. Lin’s research interests lie in the development and application of statistical and computational methods for 1) analysis of massive genetic and genomic data in population and medical science; and 2) analysis of complex…
Hiroto Hatabu, PhD, MD
Dr. Hiroto Hatabu is Professor of Radiology, BWH and HMS, Medical Director of Center for Pulmonary functional imaging (CPFI) and Clinical Director of the MRI Program at BWH. Dr. Hatabu is also a practicing chest radiologist and has significant research experience in lung cancer imaging for diagnosis and treatment response. In the course of the development of Center for Pulmonary Functional Imaging and Image-based Phenotyping, Dr. Hatabu has instituted the…
Hugo Aerts, PhD
Dr. Hugo Aerts is Assistant Professor of Radiation Oncology at HMS and DFCI/BWH and Director, Computational Imaging and Bioinformatics Laboratory, DFCI. He is a pioneer in the area of Radiomics, combining computational biology techniques with image analysis to improve precision in the use on radiation in lung cancer.
Raymond Mak, MD
Dr. Raymond Mak is Assistant Professor of Radiation Oncology, BWH/DFCI/HMS. Dr. Mak is a radiation oncologist specializing in the treatment of patients with lung cancer, and will provide expertise in designing clinical outcomes research in early stage (I-III) lung cancer, utilizing nested cohorts within the BLCS cohort, and collected tumor genotype/phenotype data. He will also provide experience in re-purposing genomic, imaging and clinical datasets from within the BLCS cohort to…
John Iafrate, MD, PhD
Dr. John Iafrate is the director of the Center for Integrated Diagnostics, a clinical laboratory for molecular diagnostics at the MGH. He oversees the Translational Research Laboratory (TRL), a shared effort of the Pathology Department and Mass General Cancer Center. The TRL provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. Dr. Iafrate received his MD and PhD from the State University of New York at…
Yi Li, PhD, MS
Dr. Yi Li is a Professor of Biostatistics at the University of Michigan. His expertise is in developing new methods for survival analysis. His current research interests are survival analysis, longitudinal and correlated data analysis, measurement error problems, spatial models and clinical trial designs. His group is developing methodologies for analyzing large-scale and high-dimensional datasets, with direct applications in observational studies as well in genetics/genomics.
Dr. David Christiani
Dr. David Christiani graduated from Tufts University School of Medicine. He completed training in Preventive Medicine and Epidemiology at HSPH. In 1987, he joined the faculties of HMS and HSPH, and is currently a Professor at both schools. His research interests have emphasized environmental molecular epidemiology and biomarkers, and he is a nationally and internationally recognized leader in the field. His work has focused on gene-environment interactions in acute diseases…